| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Globin Gene Expression during Adult Definitive Erythropoiesis Mediated by GATA-1-FOG-1-Mi2 Complex Binding at the –566 GATA Site
,
,
Flávia C. Costa,1,
Halyna Fedosyuk,1
Renee Neades,1 and
Kenneth R. Peterson1,2*
Departments of Biochemistry and Molecular Biology,1 Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas 661602
Received 11 October 2007/ Returned for modification 20 November 2007/ Accepted 8 March 2008
Autonomous silencing of
-globin transcription is an important developmental regulatory mechanism controlling globin gene switching. An adult stage-specific silencer of the A
-globin gene was identified between –730 and –378 relative to the mRNA start site. A marked copy of the A
-globin gene inserted between locus control region 5' DNase I-hypersensitive site 1 and the
-globin gene was transcriptionally silenced in adult β-globin locus yeast artificial chromosome (β-YAC) transgenic mice, but deletion of the 352-bp region restored expression. This fragment reduced reporter gene expression in K562 cells, and GATA-1 was shown to bind within this sequence at the –566 GATA site. Further, the Mi2 protein, a component of the NuRD complex, was observed in erythroid cells with low
-globin levels, whereas only a weak signal was detected when
-globin was expressed. Chromatin immunoprecipitation of fetal liver tissue from β-YAC transgenic mice demonstrated that GATA-1, FOG-1, and Mi2 were recruited to the A
-globin –566 or G
-globin –567 GATA site when
-globin expression was low (day 18) but not when
-globin was expressed (day 12). These data suggest that during definitive erythropoiesis,
-globin gene expression is silenced, in part, by binding a protein complex containing GATA-1, FOG-1, and Mi2 at the –566/–567 GATA sites of the proximal
-globin promoters.
Published ahead of print on 17 March 2008.
Supplemental material for this article may be found at http://mcb.asm.org/.
Present address: Center for Lung Biology, University of Washington School of Medicine, Seattle, WA 98109.
Co-first authors: these authors contributed equally to this work.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|